联邦制药(03933)：受托人购入350万股奖励股份

智通财经11-05

智通财经APP讯，联邦制药(03933)发布公告，于2025年10月，受托人已透过市场交易购入350万股奖励股份，每股平均价格为12.905港元，以履行于2025年11月13日对已完成2024年绩效目标的承受人的归属义务。受托人将视乎市况继续于市场购买相关数目的奖励股份，并以信托形式为相关承授人持有有关奖励股份，直至奖励股份根据股份奖励计划的条款归属予有关承授人并交收为止。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2581430728?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-05 18:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581430728","market":"us","top_or_hot":-1,"title":"联邦制药(03933)：受托人购入350万股奖励股份","media":"智通财经","content":"<div>\n<p>智通财经APP讯，联邦制药(03933)发布公告，于2025年10月，受托人已透过市场交易购入350万股奖励股份，每股平均价格为12.905港元，以履行于2025年11月13日对已完成2024年绩效目标的承受人的归属义务。受托人将视乎市况继续于市场购买相关数目的奖励股份，并以信托形式为相关承授人持有有关奖励股份，直至奖励股份根据股份奖励计划的条款归属予有关承授人并交收为止。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1365644.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>联邦制药(03933)：受托人购入350万股奖励股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n联邦制药(03933)：受托人购入350万股奖励股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-05 18:42 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1365644.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，联邦制药(03933)发布公告，于2025年10月，受托人已透过市场交易购入350万股奖励股份，每股平均价格为12.905港元，以履行于2025年11月13日对已完成2024年绩效目标的承受人的归属义务。受托人将视乎市况继续于市场购买相关数目的奖励股份，并以信托形式为相关承授人持有有关奖励股份，直至奖励股份根据股份奖励计划的条款归属予有关承授人并交收为止。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1365644.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03933","symbol_name":"联邦制药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1365644.html","article_id":"2581430728","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581430728","pubTimestamp":1762339334,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，联邦制药(03933)发布公告，于2025年10月，受托人已透过市场交易购入350万股奖励股份，每股平均价格为12.905港元，以履行于2025年11月13日对已完成2024年绩效目标的承受人的归属义务。受托人将视乎市况继续于市场购买相关数目的奖励股份，并以信托形式为相关承授人持有有关奖励股份，直至奖励股份根据股份奖励计划的条款归属予有关承授人并交收为止。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"03933":"联邦制药","BK1191":"制药"},"translate_title":"United Laboratories (03933): Trustee purchases 3.5 million award shares","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03933":1.5},"content_text":"智通财经APP讯，联邦制药(03933)发布公告，于2025年10月，受托人已透过市场交易购入350万股奖励股份，每股平均价格为12.905港元，以履行于2025年11月13日对已完成2024年绩效目标的承受人的归属义务。受托人将视乎市况继续于市场购买相关数目的奖励股份，并以信托形式为相关承授人持有有关奖励股份，直至奖励股份根据股份奖励计划的条款归属予有关承授人并交收为止。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2581430728","isCrawlerRequest":true}